# Esketamine-propofol Versus Propofol for Flexible Bronchoscopy

> **NCT05643066** · PHASE4 · COMPLETED · sponsor: **Fujian Provincial Hospital** · enrollment: 246 (actual)

## Conditions studied

- Postoperative Recovery

## Interventions

- **DRUG:** 0.1 mg/kg esketamine
- **DRUG:** 0.2 mg/kg esketamine
- **DRUG:** 0.9% saline
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05643066
- **Lead sponsor:** Fujian Provincial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-21
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05643066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05643066, "Esketamine-propofol Versus Propofol for Flexible Bronchoscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05643066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*